Acarix’ coverbillede
Acarix

Acarix

Medicinsk udstyr

Malmö, Skane County 3.790 følgere

Revolutionizing cardiac diagnostics with the CADScor®System, an AI-driven tool for rapid and non-invasive CAD detection.

Om os

Acarix is a pioneering Swedish medical device company, with an expanding presence in the U.S., transforming cardiac diagnostics with AI-powered acoustic technology. Our flagship solution, the CADScor® System, can rapidly and non-invasively risk stratify Coronary Artery Disease, helping physicians confidently assess chest pain patients while reducing unnecessary, costly, and invasive procedures. With CE-mark approval and FDA De Novo clearance, the CADScor®System provides a patient-specific CAD-score with 96% confidence, streamlining decision-making in both primary and specialized care. Backed by innovation and clinical validation, Acarix is committed to optimizing healthcare efficiency and improving patient care. Acarix is listed on the Nasdaq First North Premier Growth Market in Stockholm (ticker: ACARIX) and cross-traded on the OTCQB market in the U.S. (ticker: ACIXF).

Websted
http://www.acarix.com
Branche
Medicinsk udstyr
Virksomhedsstørrelse
11-50 medarbejdere
Hovedkvarter
Malmö, Skane County
Type
Aktieselskab
Grundlagt
2009
Specialer
Acoustics, Stable Chestpain, Coronary Artery Disease, CAD og Diagnostic Aid

Beliggenheder

  • Primær

    Jungmansgatan 12

    Malmö, Skane County 211 11, SE

    Se ruten
  • Ryvangs Allé 81-83

    Hellerup, 2900, DK

    Se ruten
  • 251 W 30th St

    5th Floor

    New York, New York 10001, US

    Se ruten
  • Universitätsstraße 71

    Cologne, North Rhine-Westphalia 50931, DE

    Se ruten

Medarbejdere hos Acarix

Opdateringer

Tilsvarende sider

Finansiering

Acarix 3 runder i alt

Seneste runde

Serie ukendt
Læs mere på crunchbase